BIOMAT Database Logo BIOMAT Database Logo

High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. 1998

M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Division of Toxicology and Cancer Risk Factors, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Levels of anti-benzo[a]pyrene diol-epoxide DNA adducts were analysed by high-pressure liquid chromatography/fluorimetric detection in non-tumorous lung tissues from 20 lung cancer patients and in white blood cells from 20 polycyclic aromatic hydrocarbon exposed coke oven workers. All were current tobacco smokers. CYP1A1 mutations (MspI at 6235 nt, Ile-Val462) and GSTM1 deletion polymorphisms in each individual were analysed in genomic DNA by PCR/restriction fragment length polymorphism. Independently of the CYP1A1 genotype (1) all 23 samples in the two groups with non-detectable adducts (< 0.2 per 10(8) nt) were of GSTM1 active genotype; (2) the 17 samples with detectable adducts (> or = 0.2 per 10(8) nt) in the two groups were GSTM1*0/*0. The difference in adduct levels between GSTM1*0/*0 and GSTM1 active genotype was highly significant (p < 0.00005). Among GSTM1-deficient individuals (n = 17), a subgroup of 14 individuals with CYP1A1*1/*1 (wild-type, n = 7) or heterozygous genotype (*1/*2A or *1/*2B, n = 7) showed low levels of BPDE DNA-adducts (range: 0.2-1.3 per 10(8) nt). (3) Three individuals with the rare combination CYP1A1*2A/*2A or *2A/*B and GSTM1*0/*0 showed significantly higher adduct levels (median: 17.4 adducts/10(8) nt, range 1.9-44; p = 0.017). Therefore, combination of homozygous mutated CYP1A1 and GSTM1*0/*0 genotypes lead, at a similar or even lower smoking dose, to a stronger increase of anti-benzo[a]pyrene diol-epoxide DNA adduct levels than found in individuals with CYP1A1 and GSTM1 wild-type. These data provide a mechanistic understanding of epidemiological studies that correlated these 'at risk' genotypes with increased smoking-related lung cancers.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D005982 Glutathione Transferase A transferase that catalyzes the addition of aliphatic, aromatic, or heterocyclic FREE RADICALS as well as EPOXIDES and arene oxides to GLUTATHIONE. Addition takes place at the SULFUR. It also catalyzes the reduction of polyol nitrate by glutathione to polyol and nitrite. Glutathione S-Alkyltransferase,Glutathione S-Aryltransferase,Glutathione S-Epoxidetransferase,Ligandins,S-Hydroxyalkyl Glutathione Lyase,Glutathione Organic Nitrate Ester Reductase,Glutathione S-Transferase,Glutathione S-Transferase 3,Glutathione S-Transferase A,Glutathione S-Transferase B,Glutathione S-Transferase C,Glutathione S-Transferase III,Glutathione S-Transferase P,Glutathione Transferase E,Glutathione Transferase mu,Glutathione Transferases,Heme Transfer Protein,Ligandin,Yb-Glutathione-S-Transferase,Glutathione Lyase, S-Hydroxyalkyl,Glutathione S Alkyltransferase,Glutathione S Aryltransferase,Glutathione S Epoxidetransferase,Glutathione S Transferase,Glutathione S Transferase 3,Glutathione S Transferase A,Glutathione S Transferase B,Glutathione S Transferase C,Glutathione S Transferase III,Glutathione S Transferase P,Lyase, S-Hydroxyalkyl Glutathione,P, Glutathione S-Transferase,Protein, Heme Transfer,S Hydroxyalkyl Glutathione Lyase,S-Alkyltransferase, Glutathione,S-Aryltransferase, Glutathione,S-Epoxidetransferase, Glutathione,S-Transferase 3, Glutathione,S-Transferase A, Glutathione,S-Transferase B, Glutathione,S-Transferase C, Glutathione,S-Transferase III, Glutathione,S-Transferase P, Glutathione,S-Transferase, Glutathione,Transfer Protein, Heme,Transferase E, Glutathione,Transferase mu, Glutathione,Transferase, Glutathione,Transferases, Glutathione
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
February 1990, Cancer research,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Benzo[a]pyrene diol epoxide-DNA cis adduct formation through a trans chlorohydrin intermediate.
March 1997, Proceedings of the National Academy of Sciences of the United States of America,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Inhibition of DNA synthesis, independent of DNA adduct formation, by benzo[a]pyrene diol epoxide in mammalian cells.
January 1983, Carcinogenesis,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Topical treatment of mice with benzo[a]pyrene or parenteral administration of benzo[a]pyrene diol epoxide-DNA to rats results in faecal excretion of a putative benzo[a]pyrene diol epoxide-deoxyguanosine adduct.
September 1987, Carcinogenesis,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Benzo[a]pyrene diol epoxide DNA adduct formation in transformable and non-transformable human foreskin fibroblast cells in vitro.
January 1982, Carcinogenesis,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Crystal structure of a benzo[a]pyrene diol epoxide adduct in a ternary complex with a DNA polymerase.
February 2004, Proceedings of the National Academy of Sciences of the United States of America,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA.
March 1992, Proceedings of the National Academy of Sciences of the United States of America,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Determinants of anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytes of the general population.
December 2006, Mutation research,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Detection of benzo[a]pyrene-DNA adducts in cultured cells treated with benzo[a]pyrene diol-epoxide by quantitative immunofluorescence microscopy and 32P-postlabelling; immunofluorescence analysis of benzo[a]pyrene-DNA adducts in bronchial cells from smoking individuals.
January 1988, IARC scientific publications,
M Rojas, and K Alexandrov, and I Cascorbi, and J Brockmöller, and A Likhachev, and K Pozharisski, and G Bouvier, and G Auburtin, and L Mayer, and A Kopp-Schneider, and I Roots, and H Bartsch
Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.
August 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
Copied contents to your clipboard!